Data / Form D filings / BrainCells Inc
BrainCells Inc: Form D filings
BrainCells Inc, a pharmaceuticals company in San Diego, CA, filed 4 Form D notices with the SEC between 2009 and 2012. The latest, on October 26, 2012, reports $4.1 million sold of a $9 million offering to 5 investors.
Find out what BrainCells Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3636 NOBEL DRIVE, SUITE 215, San Diego, CA, 92122
- Phone
- (858) 812-7700
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1313096
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 26, 2012 | Amendment | $9,000,000 | $4,100,000 | $4,900,000 | 5 | Dec 29, 2011 | sec.gov |
| Jan 11, 2012 | New notice | $8,000,000 | $1,978,046 | $6,021,954 | 5 | Dec 29, 2011 | sec.gov |
| Aug 1, 2011 | New notice | $14,000,000 | $994,727 | $13,005,273 | 7 | Jul 19, 2011 | sec.gov |
| Mar 31, 2009 | New notice | $135,000 | $135,000 | $0 | 1 | Mar 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Charles W. III Newhall | Director | |
| Fred H. Gage | Director | |
| David W. III Thompson | Director | |
| Carl H. Goldfischer | Director | |
| Arthur W. III Pappas | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Oct 22, 2012 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what BrainCells Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.